Canada markets close in 4 hours 4 minutes

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.0450-0.0750 (-1.82%)
As of 11:55AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
24,406
29,459
47,306
44,937
24,681
Selling General and Administrative
10,978
13,335
15,374
11,283
9,985
Total Operating Expenses
35,385
42,794
62,680
56,220
34,667
Operating Income or Loss
-35,385
-42,794
-62,680
-56,220
-34,667
Interest Expense
2,079
2,071
1,694
1,742
1,904
Total Other Income/Expenses Net
-
-
-
-
-1,754
Income Before Tax
-30,009
-37,543
-62,025
-57,776
-38,033
Income Tax Expense
-
-
-
0
-479.265
Income from Continuing Operations
-30,009
-37,543
-62,025
-57,776
-37,554
Net Income
-30,009
-37,543
-62,025
-57,776
-37,554
Net Income available to common shareholders
-30,009
-37,543
-62,025
-57,776
-37,554
Basic EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Diluted EPS
-0.78
-0.64
-1.06
-1.07
-1.11
Basic Average Shares
58,785
58,943
58,406
54,042
33,966
Diluted Average Shares
58,785
58,943
58,406
54,042
33,966